Status:
COMPLETED
Nepal Pioneer Worksite Intervention Study
Lead Sponsor:
Yale University
Collaborating Sponsors:
Harvard School of Public Health (HSPH)
National Institute of Environmental Health Sciences (NIEHS)
Conditions:
Dietary Modification
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed project will develop, implement, and test methodology for the design of an acceptable, effective intervention for diabetes prevention in a real-world setting. By determining the effective...
Detailed Description
INTRODUCTION The burden of non-communicable diseases (NCDs), such as cardiovascular disease (CVD), diabetes, cancer, and chronic obstructive pulmonary disease (COPD),are on the rise in low- and middl...
Eligibility Criteria
Inclusion
- Full time employees of DH-KUH
- 18 years or above of age
- Score 30 or more on Indian Diabetes risk score, No confirmation of diabetes and, not on diabetes medication. OR Have HbA1c of 5.7% to 6.4%. OR Prediabetes group with Fastening Blood Sugar (FBS) of 100- 126 mg/dL
- Systolic blood pressure 120 mm Hg or more or Diastolic blood pressure 80 mm Hg or more and not on blood pressure medication
Exclusion
- Less than 18 years
- On diabetes medication
- On hypertension medication
Key Trial Info
Start Date :
November 9 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2022
Estimated Enrollment :
363 Patients enrolled
Trial Details
Trial ID
NCT03447340
Start Date
November 9 2016
End Date
December 9 2022
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dhulikhel Hospital
Dhulikhel, Nepal